10 September 2009
FOR IMMEDIATE RELEASE
Genus plc
('Genus' or 'the Company')
Director/PDMR Shareholding
Of 119,386 ordinary shares of 10 pence each in the Company ('Ordinary Shares') that vested today in favour of Richard Wood, Chief Executive, under the Company's Performance Share Plan (the 'Plan'), 60,290 Ordinary Shares are being retained by Richard Wood as part of his shareholding in the Company. 49,096 Ordinary Shares were today sold on behalf of Richard Wood at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Richard Wood as a result of today's vesting and a further 10,000 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Richard Wood.
Richard Wood's direct shareholding in the Company now stands at 120,595 Ordinary Shares which represent 0.203% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 223,710 conditional shares and nil-cost options under the Plan.
Of 68,220 Ordinary Shares that vested today in favour of Ian Biggs, Chief Operating Officer for the Americas, under the Plan, 26,777 Ordinary Shares are being retained by Ian Biggs as part of his shareholding in the Company. 28,055 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Ian Biggs as a result of today's vesting and a further 13,388 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Ian Biggs.
Ian Biggs' direct shareholding in the Company now stands at 30,152 Ordinary Shares which represent 0.051% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 85,932 conditional shares and nil-cost options under the Plan.
Of 42,700 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer for Europe and The Far East, under the Plan, 16,760 Ordinary Shares are being retained by Thomas Philip Acton as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Thomas Philip Acton as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Thomas Philip Acton.
Thomas Philip Acton's direct shareholding in the Company now stands at 37,864 Ordinary Shares which represent 0.064% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 78,627 conditional shares and nil-cost options under the Plan.
Of 42,700 Ordinary Shares that vested today in favour of Steve Amies, Chief Operating Officer for Global Research & Product Development, under the Plan, 16,760 Ordinary Shares are being retained by Steve Amies as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Steve Amies at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Steve Amies as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Steve Amies.
Steve Amies' direct shareholding in the Company now stands at 16,760 Ordinary Shares which represent 0.028% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 58,623 conditional shares and nil-cost options under the Plan.
For further information please contact:
Ian Farrelly Tel: 01256 345996
Group Company Secretary & General Counsel
Genus plc